These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 20506565

  • 1. Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [¹⁸F]fallypride.
    Riccardi P, Park S, Anderson S, Doop M, Ansari MS, Schmidt D, Baldwin R.
    Synapse; 2011 Feb; 65(2):99-102. PubMed ID: 20506565
    [Abstract] [Full Text] [Related]

  • 2. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.
    Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
    [Abstract] [Full Text] [Related]

  • 3. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
    Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B, Anderson S, Woodward N, Schmidt D, Baldwin R, Kessler R.
    Am J Psychiatry; 2006 Sep; 163(9):1639-41. PubMed ID: 16946193
    [Abstract] [Full Text] [Related]

  • 4. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M.
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [Abstract] [Full Text] [Related]

  • 5. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D.
    Brain Res; 2005 Jan 25; 1032(1-2):77-84. PubMed ID: 15680944
    [Abstract] [Full Text] [Related]

  • 6. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.
    Synapse; 2009 Jun 25; 63(6):447-61. PubMed ID: 19217025
    [Abstract] [Full Text] [Related]

  • 7. Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task.
    Christian BT, Lehrer DS, Shi B, Narayanan TK, Strohmeyer PS, Buchsbaum MS, Mantil JC.
    Neuroimage; 2006 May 15; 31(1):139-52. PubMed ID: 16469510
    [Abstract] [Full Text] [Related]

  • 8. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A.
    Synapse; 2010 May 15; 64(5):350-62. PubMed ID: 20029833
    [Abstract] [Full Text] [Related]

  • 9. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.
    Slifstein M, Narendran R, Hwang DR, Sudo Y, Talbot PS, Huang Y, Laruelle M.
    Synapse; 2004 Oct 15; 54(1):46-63. PubMed ID: 15300884
    [Abstract] [Full Text] [Related]

  • 10. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.
    Nucl Med Biol; 1999 Jul 15; 26(5):519-27. PubMed ID: 10473190
    [Abstract] [Full Text] [Related]

  • 11. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults.
    Oswald LM, Wand GS, Wong DF, Brown CH, Kuwabara H, Brašić JR.
    Neuroimage; 2015 Jun 15; 113():26-36. PubMed ID: 25795343
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [18F]Fallypride.
    Naylor JE, Hiranita T, Matazel KS, Zhang X, Paule MG, Goodwin AK.
    Drug Alcohol Depend; 2017 Oct 01; 179():254-259. PubMed ID: 28818716
    [Abstract] [Full Text] [Related]

  • 13. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P.
    Synapse; 2010 Apr 01; 64(4):313-22. PubMed ID: 19957365
    [Abstract] [Full Text] [Related]

  • 14. Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET.
    Smith CT, Dang LC, Burgess LL, Perkins SF, San Juan MD, Smith DK, Cowan RL, Le NT, Kessler RM, Samanez-Larkin GR, Zald DH.
    Psychopharmacology (Berl); 2019 Feb 01; 236(2):581-590. PubMed ID: 30350220
    [Abstract] [Full Text] [Related]

  • 15. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R.
    Biol Psychiatry; 2008 Jan 15; 63(2):241-4. PubMed ID: 17586476
    [Abstract] [Full Text] [Related]

  • 16. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J, Vrieze E, Koole M, Muylle T, Bormans G, Claes S, Van Laere K.
    J Nucl Med; 2012 Oct 15; 53(10):1565-72. PubMed ID: 22933820
    [Abstract] [Full Text] [Related]

  • 17. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.
    Neuropsychopharmacology; 2008 Dec 15; 33(13):3111-25. PubMed ID: 18418366
    [Abstract] [Full Text] [Related]

  • 18. Cortical dopamine release during a behavioral response inhibition task.
    Albrecht DS, Kareken DA, Christian BT, Dzemidzic M, Yoder KK.
    Synapse; 2014 Jun 15; 68(6):266-74. PubMed ID: 24677429
    [Abstract] [Full Text] [Related]

  • 19. [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.
    Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO.
    Neuroimage Clin; 2018 Jun 15; 18():433-442. PubMed ID: 29541577
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study.
    Ceccarini J, Koole M, Van Laere K.
    Addict Biol; 2022 May 15; 27(3):e13167. PubMed ID: 35470551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.